Mota-T Ciwon ƙwayar cuta, CAR T Therapy, T-Cell CAR, wakili na chimeric
Zurfafa Zurfi cikin CAR T Cell Therapy: Yaya Aiki yake?
Gano kimiyyar da ke bayan CAR T Cell therapy magani a Indiya! Bincika yadda wannan maganin juyin juya hali ke canza ƙwayoyin garkuwar jikin ku zuwa mayaƙan ciwon daji. Karanta blog ɗinmu yanzu don ƙarin koyo game da wannan maganin ban mamaki da yadda ..
T-Cell CAR, CAR far, immunotherapy, T cell far
Shin CAR T-Cell Ana Samun Farfawar Kwayoyin cuta A Indiya?
Shin kun taɓa tunanin ko akwai wata hanya mai ƙarfi don yaƙi da cutar kansa? Yanzu kawai ka yi tunanin idan wata rana ka sami haske na bege a cikin yaƙin da kake yi da kansa, maganin da ke amfani da ƙarfin garkuwar jikinka don kai hari.
IDH1 maye gurbin, olutasidenib, refractory m myeloid cutar sankarar bargo, Rezlidhia
FDA ta amince da Olutasidenib don sake dawowa ko cutar sankarar cutar sankarar myeloid mai rauni tare da maye gurbin IDH1 mai sauƙi.
Dec 2022: Hukumar Abinci da Magunguna (FDA) ta amince da capsules Olutasidenib (Rezlidhia) don manya marasa lafiya da ke da cutar sankarar bargo mai saurin yaduwa ko kuma mai jurewa (AML) waɗanda ke da maye gurbin IDH1 mai saurin kamuwa da ita azaman ganowa.
Bishiyar asparaginase erwinia chrysanthemi, Kamfanin magunguna na Jazz, Rylaze
Sabbin tsarin yin allurai don asparaginase erwinia chrysanthemi (recombinant) FDA ta amince da shi.
Dec 2022: Wani sabon jadawalin allurai na ranar Litinin-Laraba-Jumma'a don asparaginase erwinia chrysanthemi (recombinant) -rywn Hukumar Abinci da Magunguna (Rylaze, Jazz Pharmaceuticals) ta amince da shi. Marasa lafiya yakamata su karɓi 25 mg / m.
ivosidenib, NCT03173248, Servier Pharmaceuticals LLC, Tibsovo
An yarda da Ivosidenib a hade tare da azacitidine don sabon kamuwa da cutar sankarar myeloid mai tsanani.
Yuni 2022: Ivosidenib (Tibsovo, Servier Pharmaceuticals LLC) a hade tare da azacitidine an amince da shi ta Hukumar Abinci da Magunguna don sabon kamuwa da cutar sankarar bargo mai cutar sankara (AML) a cikin manya masu shekaru 75 ko sama da haka tare da ...
AZA-JMML-001, Kamfanin Celgene, myelomonocytic cutar sankarar bargo, NCT02447666, Vidaza
FDA ta amince da Azacitidine don sabon kamuwa da cutar sankarar yara myelomonocytic
Yuni 2022: FDA ta amince da miyagun ƙwayoyi azacitidine (Vidaza, Celgene Corp.) ga yara masu sabuwar cutar sankarar bargo na myelomonocytic (JMML).The pharmacokinetics, pharmacodynamics, aminci, da kuma aiki na azacitidine p..
cutar sankarar mahaifa, Cutar sankarar mahaifa, induction chemotherapy, Cutar sankarar bargo, ciwon sankarar yara
Cutar sankarar yara da maganinta
Cutar sankarar bargo a ƙuruciyar cutar sankarar bargo ita ce cutar sankara mafi yawa a cikin yara da matasa, wanda ke ɗauke da kusan 1 cikin 3 na cutar kansa. Yawancin cutar sankarar bargo na yara sune m cutar sankarar bargo ta lymphocytic (ALL) da kuma m myeloid leukemia (AML). Leu na yau da kullun..
Burkitt lymphoma, Burkitt-kamar lymphoma, Farashin DLBCL, Gaskiya, Rituxan, Rituximab
Rituximab plus chemotherapy an amince da ita ta FDA don alamun ciwon daji na yara
Maris 2022: Hukumar Abinci da Magunguna ta amince da rituximab (Rituxan, Genentech, Inc.) tare da haɗin gwiwar chemotherapy don CD20-positive diffuse big B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), Burkitt-like lymphoma.
Asciminib, na kullum myeloid cutar sankarar bargo, Novartis AG, Ph+ CML, Philadelphia chromosome, Scemblix
An yarda da Asciminib don cutar sankarar bargo na chromosome na zamani na Philadelphia
Nov 2021: An ba Asciminib (Scemblix, Novartis AG) amincewa da gaggawa ta Cibiyar Abinci da Magunguna don marasa lafiya da Philadelphia chromosome-positive myeloid leukemia (Ph + CML) a cikin lokaci na yau da kullun (CP) wanda ke da p..
bALL, Brexucabtagene autoleucel, Farashin Pharma, Tecartus, ZUMA-3
Brexucabtagene autoleucel an amince da shi ta FDA don sake dawowa ko refractory B-cell precursor m lymphoblastic cutar sankarar bargo.
October 2021: Brexucabtagene autoleucel (Tecartus, Kite Pharma, Inc.) has been approved by the Food and Drug Administration for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). In..